Insulin Glargine and cancer incidence (2011)
- Authors:
- Autor USP: KANO, EUNICE KAZUE - FCF
- Unidade: FCF
- Subjects: DIABETES MELLITUS; INSULINA
- Language: Inglês
- Imprenta:
- Source:
- Título: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 1984-8250
- Volume/Número/Paginação/Ano: v. 47, suppl. 1, p. 38 res. FCF072, 2011
- Conference titles: Science and Pharmaceutical Technology Meeting of the Pharmaceutical Sciences Faculty of the University of São Paulo
-
ABNT
UEDA, Marcela Emi e RIBEIRO, Adalton Guimarães. Insulin Glargine and cancer incidence. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 24 jan. 2026. , 2011 -
APA
Ueda, M. E., & Ribeiro, A. G. (2011). Insulin Glargine and cancer incidence. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Ueda ME, Ribeiro AG. Insulin Glargine and cancer incidence. Brazilian Journal of Pharmaceutical Sciences. 2011 ; 47 38 res. FCF072.[citado 2026 jan. 24 ] -
Vancouver
Ueda ME, Ribeiro AG. Insulin Glargine and cancer incidence. Brazilian Journal of Pharmaceutical Sciences. 2011 ; 47 38 res. FCF072.[citado 2026 jan. 24 ] - Atrioventricular block associated with the first dose of fingolimod
- Serious cardiovascular adverse drug reactions related to immunomodulators used in the treatment of multiple sclerosis
- Rituximab and hematological adverse drug reaction in patients with rheumatoid arthritis
- Risk of pancreatic cancer associated with therapy based on incretins
- Serious adverse drug reaction of immunobiological drugs used in the treatment of psoriasis
- Use of in silico study to evaluate the effects of different sampling schedules on the assessment of bioequivalence of drugs with long half-life
- Osteonecrosis of jaw in use of bisphosphonates
- Adverse drug reactions profile of new drugs for Hepatits C
- Isotretinoin use association with tetratogenic effect and psychiatric disorders: need to improve risk management
- Evaluation of the effects of different sampling schedules on the assessment of bioequivalence of long half life drug
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
